Finance Friday: 11 March 2011

(Photos8.com)

Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy, Fierce Biotech, and Venture Capital Reporter.

Biomedical/Life Sciences

Kite Pharma, a start up biotech in Los Angeles, California developing new cancer vaccine therapies, took in $15 million in Series A venture funding, from TPG Capital and other investors.

Euthymics Bioscience Inc. in Braintree, Massachusetts, developing a treatment for adult attention deficit/hyperactivity disorder, added another $4 million to its series A financing from Novartis Venture Fund and Venture Investors, among others.

Liquidia Technologies, a biotech working on immune system R&D in Research Triangle Park, North Carolina gained $10 million in equity financing from the Bill & Melinda Gates Foundation.

Pharmaron, based in China, providing biochemistry R&D services, raised $40 million in the series C financing from existing investors DCM, Legend Capital and a new investor, GL Capital Group.

Astute Medical in San Diego, California, a maker of new diagnostic tests for acute conditions that require rapid diagnosis, added $13 million in series B equity financing from Domain Associates, Delphi Ventures, De Novo Ventures, and Johnson & Johnson Development Corporation.

CardioDx in Palo Alto, California, a developer of genomic tests assessing patients’ risk of developing cardiovascular disease, raised $40 million in series E equity financing, led by Longitude Capital.

Energy and Environment

Grid2Home in San Diego, California, a developer of smart grid software, says it completed a second round of equity funding valued at $2.6 million, led by Granite Ventures.

Engineering and Electronics

Samplify Systems in Santa Clara, California, a maker of analog chips whose purpose is to make the processing of real world data more sound efficient and thus less expensive, raised $11.2 million in equity funding from  Integrated Device Technology, Charles River Ventures, Formative Ventures, and Schlumberger.

Intermolecular in San Jose, California, an R&D technology developer for semiconductor and clean-energy companies, brought in $15 million in equity and securities sales.

Physical Sciences

Bubbles & beyond, a German technology company developing liquids and foams for industrial, medical, and other applications, closed a second financing round, raising EUR 1.2 million (USD 1.66 million) from existing investors LBBW Venture Capital, S-Beteiligungen, Hightech-Gruenderfonds, and KfW.

Read More: Finance Friday: 4 March 2011

*     *     *